论文部分内容阅读
对80例中晚期食管癌患者随机分为两组,单纯放疗40例(放疗组);放疗前用环磷酰胺、长春新碱、顺铂、平阳霉素联合化疗,再行放疗40例(化疗加放疗组).两组病例均采用~(60)Co 体外放射,DT60～70Gy/6～TW,近期疗效及2年生存率化疗加放疗组均优于单纯放疗组,从症状改善率,充盈缺损消退率及2年生存率3项指标观察,化疗加放疗组分别为90%、75%、55%。单纯放疗组分别为:65%、45%、38%.
Eighty patients with advanced esophageal cancer were randomly divided into two groups: 40 cases with radiotherapy alone (radiotherapy group); cyclophosphamide, vincristine, cisplatin, and pingyangmycin combined with chemotherapy before radiotherapy; 40 cases with radiotherapy (radiotherapy) Plus radiotherapy group). Both groups of patients were treated with ~(60)Co external radiation, DT60 ~ 70Gy/6 ~ TW, the short-term efficacy and 2-year survival rate of chemotherapy plus radiotherapy group were better than radiotherapy alone group, from the improvement rate of symptoms, filling The 3 indicators of defect rejection rate and 2-year survival rate were observed in 90%, 75%, and 55% of the chemotherapy and radiotherapy groups, respectively. The radiotherapy alone group was: 65%, 45%, 38%.